Wendy joined the Allen Institute in April 2026 and is currently a Scientist I in the Brain Health accelerator, working as part of the Seattle Alzheimer's Disease Atlas (SEA-AD) consortium. In this role, she builds DNA sequence-based models of brain cell types in the context of neurodegenerative disease, with the goal of understanding the regulatory mechanisms across the complex and diverse brain cell types. As part of this effort, she evaluates the functional impact of patient-specific genetic variations, helping to illuminate how individual genomic differences may contribute to disease.

Before joining the Allen Institute, Wendy earned her PhD in Computational Biology from Carnegie Mellon University. During her doctoral training, she developed deep learning models and data analysis methods to decode the relationship between sequence, structure, and function in the human genome.